The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individuals
about
Remodeling of the Host Cell Plasma Membrane by HIV-1 Nef and Vpu: A Strategy to Ensure Viral Fitness and PersistenceChallenges and Opportunities for T-Cell-Mediated Strategies to Eliminate HIV ReservoirsConformational Masking and Receptor-Dependent Unmasking of Highly Conserved Env Epitopes Recognized by Non-Neutralizing Antibodies That Mediate Potent ADCC against HIV-1Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus MacaquesMembrane-associated GRP78 helps subgroup J avian leucosis virus enter cellsInsufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cellsSurvivors Remorse: antibody-mediated protection against HIV-1.Soluble Envelope Glycoprotein Trimers from a CD4-Independent HIV-1 Elicit Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies in Guinea PigsTetherin/BST-2: Restriction Factor or Immunomodulator?A Genetic Screen Identifies a Critical Role for the WDR81-WDR91 Complex in the Trafficking and Degradation of Tetherin.Slaying the Trojan horse: natural killer cells exhibit robust anti-HIV-1 antibody-dependent activation and cytolysis against allogeneic T cellsCD4 mimetics sensitize HIV-1-infected cells to ADCC.Targeting HIV Reservoir in Infected CD4 T Cells by Dual-Affinity Re-targeting Molecules (DARTs) that Bind HIV Envelope and Recruit Cytotoxic T Cells.Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1HIV-1 gp120 envelope glycoprotein determinants for cytokine burst in human monocytes.Env-Specific IgA from Viremic HIV-Infected Subjects Compromises Antibody-Dependent Cellular CytotoxicitySmall CD4 Mimetics Prevent HIV-1 Uninfected Bystander CD4 + T Cell Killing Mediated by Antibody-dependent Cell-mediated CytotoxicityTetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection.Nef Proteins from HIV-1 Elite Controllers Are Inefficient at Preventing Antibody-Dependent Cellular CytotoxicityThe role of Fc receptors in HIV prevention and therapy.Co-receptor Binding Site Antibodies Enable CD4-Mimetics to Expose Conserved Anti-cluster A ADCC Epitopes on HIV-1 Envelope Glycoproteins.Molecular basis for epitope recognition by non-neutralizing anti-gp41 antibody F240First Phase I human clinical trial of a killed whole-HIV-1 vaccine: demonstration of its safety and enhancement of anti-HIV antibody responses.Can HIV-1-Specific ADCC Assist the Clearance of Reactivated Latently Infected Cells?Increased, durable B-cell and ADCC Responses Associated with T-helper Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site.HIV-1 Vpu Downmodulates ICAM-1 Expression, Resulting in Decreased Killing of Infected CD4+ T Cells by NK CellsMonoclonal Antibodies Specific for the V2, V3, CD4-Binding Site, and gp41 of HIV-1 Mediate Phagocytosis in a Dose-Dependent MannerImpaired Downregulation of NKG2D Ligands by Nef Proteins from Elite Controllers Sensitizes HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity.Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells.Highly individual patterns of virus-immune IgG effector responses in humans.Lack of ADCC Breadth of Human Nonneutralizing Anti-HIV-1 Antibodies.Pharmacologic Inhibition of Nedd8 Activation Enzyme Exposes CD4-Induced Epitopes within Env on Cells Expressing HIV-1.Killed whole-HIV vaccine; employing a well established strategy for antiviral vaccines.Natural Killer (NK) Cell Education Differentially Influences HIV Antibody-Dependent NK Cell Activation and Antibody-Dependent Cellular Cytotoxicity.Unlocking HIV-1 Env: implications for antibody attack.Mutation of the Putative Immunosuppressive Domain of the Retroviral Envelope Glycoprotein Compromises Infectivity.Anti-HIV-1 ADCC Antibodies following Latency Reversal and Treatment Interruption.BST-2 Expression Modulates Small CD4-Mimetic Sensitization of HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity.Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses.Short Communication: Small-Molecule CD4 Mimetics Sensitize HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity by Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Nonhuman Primates.
P2860
Q26767362-621CAD47-6B48-408A-B7A2-4ABD2D9DA4F1Q26781511-AC492FBF-9AA0-45DF-B20D-A458B43A6434Q26782237-A1173B19-3596-43EB-9DAF-DA801EA523A5Q27318508-9B8B0202-932A-427F-A1D3-35B36C362B74Q27468774-339CFD67-3CF4-4FCD-B9B6-71E3CEB695E6Q28068375-4F8FB898-CE0F-4819-AAF9-F36984F7AF0AQ30238730-22D8B2D7-5D6E-4353-8B6C-90DDC462B83CQ30278897-CD20440C-C042-410C-BC69-B4C7E067B4A3Q30385433-FC7AA1EC-CD9F-4DAA-B11B-9CA424A8A27AQ33292303-77E6B268-0850-44DA-941F-1DE2E3195EBCQ34992670-537B878F-7457-48B4-9CD5-D9C227FB206FQ35644696-ACB865CF-8662-4818-BF4C-807E0A8B7D79Q35833324-0EB9C896-6AFB-41D1-804F-2E768AF7969FQ35913921-6B265B86-B737-47EA-B16E-1837B2AC4CACQ36323975-F23DCF7C-487C-4860-BC47-59FF4BDEEBFBQ36434229-F26744E2-D0A7-4C88-A8F2-2C78C890D95EQ36538762-7DF3587F-EE18-4821-88FE-8E383E6D8429Q36548512-535C4C00-BFFA-4E2E-A1B4-DBFE60027225Q36736588-9A5917DB-FAE7-49B3-90F9-5E1F6033CF5BQ37113972-733912E6-EA61-4830-A533-0CA0B767F9E3Q37363561-17D4FBB9-7A7C-4D2C-B971-36552DB4EC90Q37402557-5399E133-20E2-4C1F-8285-1C64F4CDE706Q37449883-24FE5130-DEAE-4F71-B1DD-6D7AE430053AQ38527822-6ADE15CC-F859-481C-BE37-BACD6E67BFFEQ38658529-773C0247-5298-4C96-AE58-C0F4F97C58FCQ38718438-EB314D3E-A1C3-430E-89BD-17400C7EAD4CQ38719420-246DBF6F-E4F1-4970-899A-B3493911B8D9Q38725490-C196A428-650C-4440-8749-4969BE194B4EQ38812544-7087335D-DE69-4FBD-A47E-0D3F1031F15FQ38953491-0118DD10-197F-4424-9376-06CF6B1F4DB3Q38998925-1036B0EB-5A87-4770-8F59-775D3A82FE73Q39604750-078DD19B-C211-4C23-AB84-2AB848A3CA4DQ40047279-F9F0F4BF-B822-44F2-9276-77F911C3BA3EQ40052007-0B9BC4E8-F5E3-4907-9FD1-BBC56B88B43DQ40053224-83B702EC-F815-4730-B61B-52D1D583112FQ40080881-6199E9AD-D638-4538-AAE9-72A3C926A5D6Q40187580-B0090127-970A-4353-BFF9-BEB6218ABBB4Q40279352-70588126-77BF-42E4-A02C-57EE33D1CD9DQ40366464-093AF518-C312-4757-ADB8-69A3F8D7E34BQ40450993-B7AF5B8A-6F4D-4659-B331-290D11D613F9
P2860
The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individuals
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The HIV-1 gp120 CD4-bound conf ...... rom HIV-1-infected individuals
@ast
The HIV-1 gp120 CD4-bound conf ...... rom HIV-1-infected individuals
@en
The HIV-1 gp120 CD4-bound conf ...... rom HIV-1-infected individuals
@nl
type
label
The HIV-1 gp120 CD4-bound conf ...... rom HIV-1-infected individuals
@ast
The HIV-1 gp120 CD4-bound conf ...... rom HIV-1-infected individuals
@en
The HIV-1 gp120 CD4-bound conf ...... rom HIV-1-infected individuals
@nl
prefLabel
The HIV-1 gp120 CD4-bound conf ...... rom HIV-1-infected individuals
@ast
The HIV-1 gp120 CD4-bound conf ...... rom HIV-1-infected individuals
@en
The HIV-1 gp120 CD4-bound conf ...... rom HIV-1-infected individuals
@nl
P2093
P2860
P356
P1433
P1476
The HIV-1 gp120 CD4-bound conf ...... rom HIV-1-infected individuals
@en
P2093
Cécile Tremblay
Daniel E Kaufmann
Jonathan Richard
Laurie-Anne Batraville
Mathieu Coutu
Maxime Veillette
Michel Roger
Nicole Bernard
Olina Dagher
P2860
P304
P356
10.1128/JVI.02868-14
P407
P50
P577
2014-10-22T00:00:00Z